{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:55:35Z","timestamp":1791593735678,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":643,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Meningoencephalitis of unknown origin (MUO) comprises a group of noninfectious inflammatory diseases affecting the central nervous system of dogs. Previous studies have reported individual risk factors for survival but prognostication for MUO remains challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Identify clinical prognostic variables in dogs with MUO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>A retrospective study of 447 dogs presented to 2 UK referral hospitals and diagnosed with MUO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records of dogs diagnosed with MUO were retrospectively reviewed. Multivariable logistic regression was used for the identification of risk factors for survival and Cox proportional hazards analysis for the identification of risk factors for clinical relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-two percent (366\/447) of dogs with presumptive MUO survived to discharge and 63.5% (284\/447) were alive at 6\u2009months; 36% of the latter (103\/284) had persistent neurological deficits. Breed (pugs; P\u2009=\u2009.03), epileptic seizures (P\u2009&amp;lt;\u2009.001), paresis (P\u2009&amp;lt;\u2009.001), and higher neurodisability scale (NDS) score (P\u2009&amp;lt;\u2009.001) at presentation were negatively associated with survival to 6\u2009months. Dogs with persistent deficits had higher NDS scores on presentation (P\u2009=\u2009.001). Median follow-up time was 11\u2009months (interquartile range [IQR], 1-24) and 50.6% (160\/316) relapsed during treatment (median time to relapse, 7\u2009months; IQR, 2-15). Incomplete resolution of the clinical signs during the 6\u2009months after diagnosis (P\u2009&amp;lt;\u2009.001), higher NDS score (P\u2009&amp;lt;\u2009.001), and longer duration of the clinical signs (P\u2009&amp;lt;\u2009.001) were associated with relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Knowledge of risk factors associated with survival, incomplete recovery and clinical relapse in MUO can help guide monitoring and treatment and improve owner communications regarding prognosis for this debilitating disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.17037","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:20:14Z","timestamp":1710404414000},"page":"1583-1590","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prognosis in meningoencephalitis of unknown origin in dogs: Risk factors associated with survival, clinical relapse, and long-term disability"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-9801","authenticated-orcid":false,"given":"Rita","family":"Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Small Animal Teaching Hospital, University of Liverpool Department of Veterinary Science, , Neston,","place":["UK"]},{"name":"Institute of Lifecourse and Medical Sciences, University of Liverpool Department of Musculoskeletal and Ageing Science, , Neston,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-2152","authenticated-orcid":false,"given":"Steven","family":"De Decker","sequence":"additional","affiliation":[{"name":"Royal Veterinary College, University of London Department of Clinical Science and Services, , Hatfield,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0727-8265","authenticated-orcid":false,"given":"Gemma","family":"Walmsley","sequence":"additional","affiliation":[{"name":"Small Animal Teaching Hospital, University of Liverpool Department of Veterinary Science, , Neston,","place":["UK"]},{"name":"Institute of Lifecourse and Medical Sciences, University of Liverpool Department of Musculoskeletal and Ageing Science, , Neston,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Maddox","sequence":"additional","affiliation":[{"name":"Small Animal Teaching Hospital, University of Liverpool Department of Veterinary Science, , Neston,","place":["UK"]},{"name":"Institute of Lifecourse and Medical Sciences, University of Liverpool Department of Musculoskeletal and Ageing Science, , Neston,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,1]]},"reference":[{"key":"2026020305112318500_jvim17037-bib-0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tvjl.2018.12.007","article-title":"Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: a review","volume":"244","author":"Cornelis","year":"2019","journal-title":"Vet J"},{"key":"2026020305112318500_jvim17037-bib-0002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cvsm.2014.07.009","article-title":"Perspectives on meningoencephalomyelitis of unknown origin","volume":"44","author":"Coates","year":"2014","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020305112318500_jvim17037-bib-0003","article-title":"Inflammatory disease affecting the central nervous system in dogs: a retrospective study in England (2010-2019)","volume":"8","author":"Gon\u00e7alves","year":"2021","journal-title":"Front Vet Sci"},{"key":"2026020305112318500_jvim17037-bib-0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/vr.101431","article-title":"Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol","volume":"172","author":"Lowrie","year":"2013","journal-title":"Vet Rec"},{"key":"2026020305112318500_jvim17037-bib-0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tvjl.2016.05.008","article-title":"Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology","volume":"214","author":"Cornelis","year":"2016","journal-title":"Vet J"},{"key":"2026020305112318500_jvim17037-bib-0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2022.105884","article-title":"Risk factors for early death or euthanasia within 100\u2009days of diagnosis in dogs with meningoencephalitis of unknown origin","volume":"287","author":"Lawn","year":"2022","journal-title":"Vet J"},{"key":"2026020305112318500_jvim17037-bib-0007","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/vru.12434","article-title":"Retrospective study evaluating associations between midline brain shift on magnetic resonance imaging and survival in dogs diagnosed with meningoencephalitis of unknown etiology","volume":"58","author":"Oliphant","year":"2017","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020305112318500_jvim17037-bib-0008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/vec.12399","article-title":"Retrospective evaluation of combined mycophenolate mofetil and prednisone treatment for meningoencephalomyelitis of unknown etiology in dogs: 25 cases (2005-2011)","volume":"26","author":"Barnoon","year":"2016","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"2026020305112318500_jvim17037-bib-0009","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2460\/javma.1999.215.10.1463","article-title":"Clinical findings, treatment, and outcome of dogs with status epilepticus or cluster seizures: 156 cases (1990-1995)","volume":"215","author":"Bateman","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"2026020305112318500_jvim17037-bib-0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1939-1676.2007.tb02934.x","article-title":"Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004)","volume":"21","author":"Coates","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020305112318500_jvim17037-bib-0011","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/jvim.16717","article-title":"Development of a reliable clinical assessment tool for meningoencephalitis in dogs: the neurodisability scale","volume":"37","author":"Gon\u00e7alves","year":"2023","journal-title":"J Vet Intern Med"},{"key":"2026020305112318500_jvim17037-bib-0012","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.925774","article-title":"Treatment with cytarabine at initiation of therapy with cyclosporine and glucocorticoids for dogs with meningoencephalomyelitis of unknown origin is not associated with improved outcomes","volume":"9","author":"Barber","year":"2022","journal-title":"Front Vet Sci"},{"key":"2026020305112318500_jvim17037-bib-0013","doi-asserted-by":"crossref","DOI":"10.1136\/vr.106019","article-title":"Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin","volume":"187","author":"Stee","year":"2020","journal-title":"Vet Rec"},{"key":"2026020305112318500_jvim17037-bib-0014","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1748-5827.2012.01251.x","article-title":"Canine idiopathic epilepsy: prevalence, risk factors and outcome associated with cluster seizures and status epilepticus","volume":"53","author":"Monteiro","year":"2012","journal-title":"J Small Anim Pract"},{"key":"2026020305112318500_jvim17037-bib-0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/vr.103355","article-title":"Quality-of-life aspects in idiopathic epilepsy in dogs","volume":"179","author":"Wessmann","year":"2016","journal-title":"Vet Rec"},{"key":"2026020305112318500_jvim17037-bib-0016","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/vr.103360","article-title":"Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs","volume":"177","author":"Packer","year":"2015","journal-title":"Vet Rec"},{"key":"2026020305112318500_jvim17037-bib-0017","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1939-1676.2008.0137.x","article-title":"Epidemiology of necrotizing meningoencephalitis in pug dogs","volume":"22","author":"Levine","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020305112318500_jvim17037-bib-0018","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1212\/01.WNL.0000036907.37650.8E","article-title":"Course and prognosis in early-onset MS: comparison with adult-onset forms","volume":"59","author":"Simone","year":"2002","journal-title":"Neurology"},{"key":"2026020305112318500_jvim17037-bib-0019","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","volume":"126","author":"Confavreux","year":"2003","journal-title":"Brain"},{"key":"2026020305112318500_jvim17037-bib-0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-510X(99)00143-4","article-title":"A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials","volume":"168","author":"Amato","year":"1999","journal-title":"J Neurol Sci"},{"key":"2026020305112318500_jvim17037-bib-0021","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.58.3.300","article-title":"Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events","volume":"58","author":"Trojano","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026020305112318500_jvim17037-bib-0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092761","article-title":"Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review","volume":"9","author":"Stellmann","year":"2014","journal-title":"PloS One"},{"key":"2026020305112318500_jvim17037-bib-0023","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1114798","article-title":"New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: a review of 671 cases","volume":"10","author":"Jeffery","year":"2023","journal-title":"Front Vet Sci"},{"key":"2026020305112318500_jvim17037-bib-0024","first-page":"110","article-title":"Necrotizing meningoencephalitis of pug dogs associates with dog leukocyte antigen class II and resembles acute variant forms of multiple sclerosis","volume":"76","author":"Greer","year":"2010","journal-title":"Tissue Antigens"},{"key":"2026020305112318500_jvim17037-bib-0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280864","article-title":"Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin","volume":"18","author":"Pr\u00fcmmer","year":"2023","journal-title":"PloS One"},{"key":"2026020305112318500_jvim17037-bib-0026","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0404.1992.tb04031.x","article-title":"Early prognostic factors for disability in multiple sclerosis, a European multicenter study","volume":"85","author":"Riise","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"2026020305112318500_jvim17037-bib-0027","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/030098588902600301","article-title":"A necrotizing meningoencephalitis of pug dogs","volume":"26","author":"Cordy","year":"1989","journal-title":"Vet Pathol"},{"key":"2026020305112318500_jvim17037-bib-0028","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1939-1676.2009.0306.x","article-title":"Magnetic resonance imaging characteristics of necrotizing meningoencephalitis in pug dogs","volume":"23","author":"Young","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020305112318500_jvim17037-bib-0029","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1740-8261.2008.00400.x","article-title":"Magnetic resonance imaging findings in histologically confirmed pug dog encephalitis","volume":"49","author":"Flegel","year":"2008","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020305112318500_jvim17037-bib-0030","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1292\/jvms.13-0252","article-title":"Serum glial fibrillary acidic protein as a specific marker for necrotizing meningoencephalitis in pug dogs","volume":"75","author":"Miyake","year":"2013","journal-title":"J Vet Med Sci"},{"key":"2026020305112318500_jvim17037-bib-0031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/vr.161.8.261","article-title":"Glial fibrillary acidic protein (GFAP) and anti-GFAP autoantibody in canine necrotising meningoencephalitis","volume":"161","author":"Toda","year":"2007","journal-title":"Vet Rec"},{"key":"2026020305112318500_jvim17037-bib-0032","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/1352458518819380","article-title":"Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity","volume":"26","author":"H\u00f6gel","year":"2020","journal-title":"Mult Scler"},{"key":"2026020305112318500_jvim17037-bib-0033","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/NXI.0000000000200052","article-title":"Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis","volume":"10","author":"Barro","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026020305112318500_jvim17037-bib-0034","article-title":"Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis","volume":"2","author":"Traboulsee","year":"2016","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"2026020305112318500_jvim17037-bib-0035","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2442","article-title":"Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting","volume":"4","author":"von Gumberz","year":"2016","journal-title":"PeerJ"},{"key":"2026020305112318500_jvim17037-bib-0036","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jnnp-2011-301178","article-title":"Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon \u03b2-1b trial in multiple sclerosis","volume":"83","author":"Goodin","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026020305112318500_jvim17037-bib-0037","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0317167100014244","article-title":"Treatment optimization in MS: Canadian MS Working Group updated recommendations","volume":"40","author":"Freedman","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"2026020305112318500_jvim17037-bib-0038","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archneur.63.12.1686","article-title":"Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review","volume":"63","author":"Langer-Gould","year":"2006","journal-title":"Arch Neurol"},{"key":"2026020305112318500_jvim17037-bib-0039","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(20)30067-3","article-title":"Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study","volume":"19","author":"He","year":"2020","journal-title":"Lancet Neurol"},{"key":"2026020305112318500_jvim17037-bib-0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11940-021-00677-1","article-title":"Early aggressive treatment approaches for multiple sclerosis","volume":"23","author":"Simpson","year":"2021","journal-title":"Curr Treat Options Neurol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/38\/3\/1583\/66721142\/jvim17037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/38\/3\/1583\/66721142\/jvim17037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:11:33Z","timestamp":1770113493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/38\/3\/1583\/8456051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.17037","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,5,1]]},"assertion":[{"value":"2023-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}